Dopamine News and Research

RSS
Dopamine is a hormone and neurotransmitter occurring in a wide variety of animals, including both vertebrates and invertebrates. In the brain, this phenethylamine functions as a neurotransmitter, activating the five types of dopamine receptors — D1, D2, D3, D4 and D5, and their variants. Dopamine is produced in several areas of the brain, including the substantia nigra and the ventral tegmental area. Dopamine is also a neurohormone released by the hypothalamus. Its main function as a hormone is to inhibit the release of prolactin from the anterior lobe of the pituitary. Dopamine has many functions in the brain, including important roles in behavior and cognition, motor activity, motivation and reward, inhibition of prolactin production (involved in lactation), sleep, mood, attention, and learning. Dopaminergic neurons (i.e., neurons whose primary neurotransmitter is dopamine) are present chiefly in the ventral tegmental area (VTA) of the midbrain, substantia nigra pars compacta, and arcuate nucleus of the hypothalamus.
Cyrenaic announces results of CYR-101 Phase IIa clinical trial for schizophrenia

Cyrenaic announces results of CYR-101 Phase IIa clinical trial for schizophrenia

CAMH neuroscientists develop novel protein peptide for targeted treatment of depression

CAMH neuroscientists develop novel protein peptide for targeted treatment of depression

XenoPort receives grant from Michael J. Fox Foundation to support Parkinson's disease therapies

XenoPort receives grant from Michael J. Fox Foundation to support Parkinson's disease therapies

Parkinson Society Canada awards Quebec scientists $573,384 for research

Parkinson Society Canada awards Quebec scientists $573,384 for research

Scientists solve receptor structure that responds to neurotransmitter dopamine

Scientists solve receptor structure that responds to neurotransmitter dopamine

Alkermes's ALKS 33 drug candidate offers potential treatment for multiple disease indications

Alkermes's ALKS 33 drug candidate offers potential treatment for multiple disease indications

Santarus announces commercial U.S. launch of CYCLOSET for type 2 diabetes mellitus

Santarus announces commercial U.S. launch of CYCLOSET for type 2 diabetes mellitus

Neurologix third quarter net loss decreases to $2.3 million

Neurologix third quarter net loss decreases to $2.3 million

Exhausted neurons die prematurely and trigger disease symptoms

Exhausted neurons die prematurely and trigger disease symptoms

Enrollment complete in Nabi's second NicVAX Phase III clinical trial for nicotine addiction

Enrollment complete in Nabi's second NicVAX Phase III clinical trial for nicotine addiction

Phase III study suggests CYCLOSET tablets improve glycemic control

Phase III study suggests CYCLOSET tablets improve glycemic control

Catalyst’s CPP-115 improves retinal safety profile than vigabatrin

Catalyst’s CPP-115 improves retinal safety profile than vigabatrin

New computational techniques to overcome obstacles in hard-to-study genes

New computational techniques to overcome obstacles in hard-to-study genes

Tel Aviv University research links obsessive-compulsive disorder to common childhood illness

Tel Aviv University research links obsessive-compulsive disorder to common childhood illness

Dopamine vital for rhythmic expression in specific brain regions: Research

Dopamine vital for rhythmic expression in specific brain regions: Research

Study finds different activity patterns of genes in brain of individuals with different genetic backgrounds

Study finds different activity patterns of genes in brain of individuals with different genetic backgrounds

Research offers important insight into symptoms of Parkinson's disease

Research offers important insight into symptoms of Parkinson's disease

Ceregene commences enrollment in CERE-120 Phase 2b study for Parkinson's disease

Ceregene commences enrollment in CERE-120 Phase 2b study for Parkinson's disease

Dopamine behind mens susceptibility to alcoholism

Dopamine behind mens susceptibility to alcoholism

Study suggests treating RLS may improve sleep and quality of life in people with fibromyalgia

Study suggests treating RLS may improve sleep and quality of life in people with fibromyalgia

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.